Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 10, Issue 4
High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
This article has a correction. Please see:
Correction: High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC - June 01, 2022
PDF
PDF +
Supplementary
Material
Immunotherapy biomarkers
Original research
High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
Online download statistics by month:
Online download statistics by month: April 2022 to February 2026
Abstract
Full
Pdf
Apr 2022
335
356
108
May 2022
827
869
295
Jun 2022
468
482
114
Jul 2022
157
164
23
Aug 2022
155
161
26
Sep 2022
154
157
30
Oct 2022
144
151
35
Nov 2022
120
123
22
Dec 2022
89
90
17
Jan 2023
70
70
26
Feb 2023
66
67
23
Mar 2023
47
50
26
Apr 2023
47
49
16
May 2023
38
38
14
Jun 2023
23
23
6
Jul 2023
35
35
19
Aug 2023
43
43
17
Sep 2023
30
30
19
Oct 2023
31
31
15
Nov 2023
44
44
11
Dec 2023
24
24
12
Jan 2024
32
33
12
Feb 2024
29
29
20
Mar 2024
37
37
28
Apr 2024
22
22
17
May 2024
39
40
14
Jun 2024
30
30
18
Jul 2024
50
51
12
Aug 2024
17
17
6
Sep 2024
46
46
18
Oct 2024
37
37
15
Nov 2024
29
30
16
Dec 2024
57
59
14
Jan 2025
37
37
18
Feb 2025
102
102
13
Mar 2025
49
52
23
Apr 2025
53
53
16
May 2025
26
27
16
Jun 2025
28
28
13
Jul 2025
1
1
0
Feb 2026
1
1
0
Total
3669
3789
1163
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?